Genomic and immune microenvironment profiling in a case of metastatic intrathyroid thymic carcinoma.
Hiroki IshiiTakahiro TsujikawaNaoki OishiArisa KinouchiKaname SakamotoJunichi MitsudaHiroshi OgiKyoko ItohTetsuo KondoShigeru HiranoDaiju SakuraiPublished in: Clinical case reports (2022)
Metastatic intrathyroid thymic carcinoma (ITTC) is a rare cancer with no effective drugs for controlling. This case report has shown genomic and immune microenvironment profiles in metastatic ITTC and emphasized an immunosuppression via a PD-1/PD-L1 pathway, possibly strengthening the rationale for immune checkpoint blockade as a novel treatment.